|
Location: 6001 Executive Boulevard, Rockville, Maryland
Neuroscience Conference Center Rooms C and D
DRAFT AGENDA
 |
Closed Session |
9:30 a.m. |
Review of Grant Applications |
|
Margaret Chesney, Ph.D.
Deputy Director, NCCAM
Director, DERT, NCCAM
This portion of the meeting is being closed to the public in accordance with the
provisions set forth in Section 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).
Review of Confidentiality and Conflict of Interest Rules
|
| 10:45 a.m. |
BREAK
|
| 12:00 p.m. |
LUNCH
|
Open Session |
1:00 p.m. |
Call to Order, Meeting Procedures
Jane Kinsel, Ph.D., M.B.A.
Associate Director for Science
Policy and Operations, NCCAM
|
| 1:10 p.m. |
Opening Remarks
Stephen Straus, M.D.
Director, NCCAM
|
| 1:40 p.m. |
Concept Clearance
NCCAM Exploratory/Developmental Grant for Clinical Studies (R21)
NCCAM Staff
|
| 2:30 p.m. |
BREAK
|
| 3:00 p.m. |
Overview of Activities at the Food and Drug Administration
Mark McClellan, M.D.
Commissioner, FDA
|
| 3:30 p.m. |
BREAK
|
| 3:45 p.m. |
Working Group on Cancer: A Proposal
Jane Kinsel, Ph.D., M.B.A.
Associate Director for Science Policy and Operations, NCCAM
|
| 4:15 p.m. |
Cancer Patients and CAM: Exploring Information Needs
Chris Thomsen
Director, Office of Communications and Public Liaison, NCCAM
|
| 4:45 p.m. |
Public Comment Session
|
| 5:15 p.m. |
ADJOURNMENT
|
|
Future Meeting Dates
2003 - September 8
2004 - January 30, June 4, September 10 |
|
